Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

The session titled “Defeating Cancer by Curing Infections” at European Society of Clinical Microbiology and Infectious ...

This is DTIL’s lead, fully owned in vivo gene editing program aimed at curing chronic hepatitis ... hepatitis B virus (HBV) — and inactivating integrated HBV DNA in liver cells (hepatocytes).

It’s a biologic vaccine made using modified yeast cells that produce a protein from the hepatitis B virus. It’s available only as a brand-name vaccine. It isn’t available in a biosimilar form.

Virus-specific T-cell measurement is made easier to enable better understanding of immune responses in patients and ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...